GLADSTONE, N.J. — Propel Health Medical Affairs (PHMA), a full-service medical communications agency within the Propel Health network, announced that Daniel Snyder, PhD, has joined the company as Executive Vice President, Advisory Services.
In his new role, Dr. Snyder will work closely with pharmaceutical and biotechnology clients to develop and execute Medical Affairs launch strategies aimed at supporting successful product introductions. The company said he will advise clients across all stages of pre-launch and launch preparation.
Dr. Snyder brings more than 20 years of leadership experience guiding launch planning for life science organizations. His background spans integrated evidence planning, scientific strategy, readiness in 11 therapeutic areas, and building Medical Affairs, HEOR and RWE functions. He has led and supported launches of multiple breakthrough medicines and is known for helping teams align strategically, strengthen medical expert engagement, and communicate scientific value clearly and compliantly.
PHMA said clients will benefit from his hands-on approach in areas such as advisory board support, scientific engagement planning, omnichannel strategy, payer and provider communication, and operational implementation across launch milestones.
“I am delighted to have Daniel join us not just for his expertise, but for his wisdom, honesty, and unwavering dedication to helping our partners succeed,” said Jeff Keller, President of Propel Health Medical Affairs. “He’s a patient listener, a thoughtful advisor, creative and solution-oriented, and a genuinely kind person. Daniel’s integrity and commitment shine through in every project, and our clients will immediately feel the difference in working with him.”
